| |
We explain what types of agency meetings can be sought in the EU, US, Japan, China, and Canada, and provide details to guide requesting and preparing for agency interactions. Learn more.
|
|
Today’s Big NewsAug 11, 2023 |
| By Nick Paul Taylor The dream of using anti-CD47 drugs to boost chemotherapy in blood cancer patients is unraveling fast. Weeks after Gilead Sciences stopped its phase 3 trial for futility, ALX Oncology has called a halt to a pair of studies for a rival therapy. |
|
|
|
By Nick Paul Taylor Atreca is taking drastic action to keep the show on the road into next year. With its cash running low and share price in the basement, the biotech has decided to stop work on its lead candidate, switch its focus to preclinical antibody-drug conjugates and lay off 40% of its staff. |
By Max Bayer,Gabrielle Masson A topsy turvy year for Mirati has taken its latest turn, with CEO David Meek stepping down this week effective immediately. |
By Fraiser Kansteiner Less than a month after the family of Henrietta Lacks reached a settlement with Thermo Fisher over its use of Lacks’ cells, another drugmaker stands accused of profiting from a racist medical system. |
By Andrea Park Not to be outdone by the FDA, regulators in Europe have given the all-clear to a new indication for Theranica’s neuromodulation armband for migraine treatment. |
By Fraiser Kansteiner Frank Han, Pfizer's former director of global compliance analytics, has filed a civil complaint against the drugmaker. Han claims he was terminated for identifying potential issues relating to the Foreign Corrupt Practices Act. |
By Dave Muoio Over half of health system pharmacists say they've been at least moderately impacted by drug shortages, and nearly all say they've had to get creative with dispensing and purchasing. |
By Noah Tong A report from AARP broke down how popular brand-name drugs have continued to rise in price and exceed inflation. |
By Teresa Carey This week on "The Top Line," we discuss left-handedness and its significance in neurodevelopmental and psychiatric disorder research. |
By Angus Liu Astellas has won an FDA nod for a geographic atrophy therapy from its acquisition of Iveric Bio. A Fierce Biotech report examined Singapore's search for its big biotech success story. AstraZeneca signed an mRNA vaccine manufacturing deal with China's CanSino Biologics. And more. |
Fierce podcastsDon’t miss an episode |
| | This week on "The Top Line," we discuss left-handedness and its significance in neurodevelopmental and psychiatric disorder research. |
|
|---|
|
|
| WhitepaperLearn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Thermo Fisher Scientific Process Liquid Preparation Services |
| WhitepaperIn oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| WhitepaperLearn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
| ResearchLearn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| Whitepaper Learn more about the current challenges and issues that eClinical technology providers are facing. Sponsored by: YPrime |
| |
|
